CRCA vs. NFXS
CRCA (ProShares Ultra CRCL) and NFXS (Direxion Daily NFLX Bear 1X Shares) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while NFXS is a Inverse Equities fund actively managed by Direxion. Both are actively managed. At a correlation of -0.19, they often move in opposite directions. CRCA charges 0.95%/yr vs 1.03%/yr for NFXS.
Performance
CRCA vs. NFXS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -56.81% return, which is significantly lower than NFXS's 26.00% return.
CRCA
- 1D
- -13.29%
- 1M
- -64.42%
- YTD
- -56.81%
- 6M
- -60.16%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NFXS
- 1D
- 1.44%
- 1M
- 23.02%
- YTD
- 26.00%
- 6M
- 25.81%
- 1Y
- 69.91%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. NFXS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -56.81% | -84.67% |
NFXS Direxion Daily NFLX Bear 1X Shares | 26.00% | 24.47% |
Correlation
The correlation between CRCA and NFXS is -0.19, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | -0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. NFXS — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
NFXS
CRCA vs. NFXS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Direxion Daily NFLX Bear 1X Shares (NFXS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | NFXS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.39 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.24 | — |
| Martin ratioReturn relative to average drawdown | — | 6.13 | — |
Loading charts...
Drawdowns
CRCA vs. NFXS - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.31%, which is greater than NFXS's maximum drawdown of -50.37%. Use the drawdown chart below to compare losses from any high point for CRCA and NFXS.
Loading charts...
Drawdown Indicators
| CRCA | NFXS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.31% | -50.37% | -43.94% |
Max Drawdown (1Y)Largest decline over 1 year | — | -31.31% | — |
Current DrawdownCurrent decline from peak | -93.38% | -11.63% | -81.75% |
Average DrawdownAverage peak-to-trough decline | -71.83% | -31.89% | -39.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 11.44% | — |
Volatility
CRCA vs. NFXS - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | NFXS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.76% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 26.25% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 194.72% | 33.78% | +160.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 194.72% | 34.63% | +160.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 194.72% | 34.63% | +160.09% |
CRCA vs. NFXS - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is lower than NFXS's 1.03% expense ratio.
Dividends
CRCA vs. NFXS - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 4.01%, more than NFXS's 2.81% yield.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
CRCA ProShares Ultra CRCL | 4.01% | 1.06% | 0.00% |
NFXS Direxion Daily NFLX Bear 1X Shares | 2.81% | 3.53% | 0.87% |
Frequently Asked Questions
CRCA and NFXS have a correlation of -0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CRCA is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA is cheaper with a 0.95% expense ratio, compared with 1.03% for NFXS.
CRCA has the higher dividend yield at 4.01%, compared with 2.81% for NFXS.
CRCA is categorized as Leveraged Equities, while NFXS is Inverse Equities. They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for CRCA and 1.03% for NFXS.
Find the right allocation for CRCA and NFXS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer